Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of comparative effectiveness research"
DOI: 10.2217/cer-2017-0024
Abstract: AIM Our study aimed at estimating differences in quality-adjusted life year (QALY) gain for patients with predominant negative symptoms of schizophrenia treated with cariprazine compared with risperidone. MATERIALS & METHODS A Markov model was built,… read more here.
Keywords: treated cariprazine; patients predominant; negative symptoms; predominant negative ... See more keywords